Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05972759 · ClinicalTrials.gov registry record · NA
Identifying the Neural Signature of Exercise to Advance Treatment of PD Cognitive Declines
A NA study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT05972759 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 25 participants.
The verdict
NCT05972759, a NA study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
Twenty-five participants with PD utilizing the Medtronic Percept PC DBS system will be enrolled for this project and complete a single bout of both FE and VE. The 150-minute experimental session will be completed in the OFF antiparkinsonian and Off-DBS state.
Interventions
- OTHER Forced and voluntary exercise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2023-08-15 |
| Est. Completion | 2026-02-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05972759
The ClinicalTrials.gov registry entry for NCT05972759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Forced and voluntary exercise is the first listed.
NCT05972759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05972759 about?
NCT05972759 is a clinical study titled "Identifying the Neural Signature of Exercise to Advance Treatment of PD Cognitive Declines". Twenty-five participants with PD utilizing the Medtronic Percept PC DBS system will be enrolled for this project and complete a single bout of both FE and VE. The 150-minute experimental session will be completed in the OFF antiparkinsonian and Off-DBS state.
What is the current status of trial NCT05972759?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2023-08-15. Estimated completion is 2026-02-12.
What interventions are being tested in trial NCT05972759?
The interventions under investigation include: Forced and voluntary exercise (OTHER).
Who is sponsoring clinical trial NCT05972759?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.